Please wait while the formulary information is being retrieved.
FINASTERIDE (finasteride)
- Benign prostatic hyperplasia with lower urinary tract sx
- Male patterned baldness
5 mg tablet
- 1 tablet (5 mg) by oral route once daily
1 mg tablet
- 1 tablet (1 mg) by oral route once daily
1 mg tablet
- 1 tablet (1 mg) by oral route once daily
5 mg tablet
- 1 tablet (5 mg) by oral route once daily
1 mg tablet
- 1 tablet (1 mg) by oral route once daily
5 mg tablet
- 1 tablet (5 mg) by oral route once daily
Benign prostatic hyperplasia with lower urinary tract sx
- 1 tablet (5 mg) by oral route once daily
Male patterned baldness
- 1 tablet (1 mg) by oral route once daily
- None
Contraindicated
- None
Severe
Moderate
- None
- Lactating mother
- Pregnancy
Contraindicated
- Suicidal ideation
Severe
Moderate
- Disease of liver
- High-grade prostate cancer
- Malignant tumor of male breast
FINASTERIDE (finasteride)
- Benign prostatic hyperplasia with lower urinary tract sx
- Male patterned baldness
- None
- Erectile dysfunction
More Frequent
Severe
Less Severe
- Gynecomastia
- High-grade prostate cancer
- Hypersensitivity drug reaction
- Skin rash
- Decrease ejaculate volume
- Hypotension
- Libido changes
- Mastalgia
- Peripheral edema
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Angioedema
- Malignant tumor of male breast
- Pruritus of skin
- Rhabdomyolysis
- Seizure disorder
- Suicidal ideation
- Urticaria
Less Severe
- Depression
- Disorder of ejaculation
- Muscle weakness
- Myalgias
- Myopathy
- Oligospermia
- Orgasm disorder
- Testicular pain
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Finasteride
Not indicated in pediatrics. No safety and efficacy studies.
- 1 Day – 18 Years
- Not indicated in pediatrics. No safety and efficacy studies.
Finasteride
- Severity Level:
X
- Additional Notes:
Contraindicated
Finasteride
Not indicated in women; potential for serious adverse effects in infant.
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Not indicated in women; potential for serious adverse effects in infant. |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Benign prostatic hyperplasia with lower urinary tract sx | |
| N40.1 | Benign prostatic hyperplasia with lower urinary tract symptoms |
| Male patterned baldness | |
| L64 | Androgenic alopecia |
| L64.0 | Drug-induced androgenic alopecia |
| L64.8 | Other androgenic alopecia |
| L64.9 | Androgenic alopecia, unspecified |
| 0-9 | A-Z |
|---|---|
| L64 | Androgenic alopecia |
| L64.0 | Drug-induced androgenic alopecia |
| L64.8 | Other androgenic alopecia |
| L64.9 | Androgenic alopecia, unspecified |
| N40.1 | Benign prostatic hyperplasia with lower urinary tract symptoms |
Formulary Reference Tool